High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms.
Antigens, Viral, Tumor
Bone Neoplasms
/ genetics
Carcinoma, Merkel Cell
/ genetics
DNA End-Joining Repair
Humans
Merkel cell polyomavirus
/ genetics
Polyomavirus Infections
/ complications
Recombination, Genetic
Skin Neoplasms
/ genetics
Tumor Virus Infections
/ complications
Viral Proteins
/ genetics
Virus Integration
Virus Replication
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
18
04
2020
accepted:
08
07
2020
revised:
03
09
2020
pubmed:
25
8
2020
medline:
23
9
2020
entrez:
25
8
2020
Statut:
epublish
Résumé
Merkel Cell Polyomavirus (MCPyV) is the etiological agent of the majority of Merkel Cell Carcinomas (MCC). MCPyV positive MCCs harbor integrated, defective viral genomes that constitutively express viral oncogenes. Which molecular mechanisms promote viral integration, if distinct integration patterns exist, and if integration occurs preferentially at loci with specific chromatin states is unknown. We here combined short and long-read (nanopore) next-generation sequencing and present the first high-resolution analysis of integration site structure in MCC cell lines as well as primary tumor material. We find two main types of integration site structure: Linear patterns with chromosomal breakpoints that map closely together, and complex integration loci that exhibit local amplification of genomic sequences flanking the viral DNA. Sequence analysis suggests that linear patterns are produced during viral replication by integration of defective/linear genomes into host DNA double strand breaks via non-homologous end joining, NHEJ. In contrast, our data strongly suggest that complex integration patterns are mediated by microhomology-mediated break-induced replication, MMBIR. Furthermore, we show by ChIP-Seq and RNA-Seq analysis that MCPyV preferably integrates in open chromatin and provide evidence that viral oncogene expression is driven by the viral promoter region, rather than transcription from juxtaposed host promoters. Taken together, our data explain the characteristics of MCPyV integration and may also provide a model for integration of other oncogenic DNA viruses such as papillomaviruses.
Identifiants
pubmed: 32833988
doi: 10.1371/journal.ppat.1008562
pii: PPATHOGENS-D-20-00800
pmc: PMC7470373
doi:
Substances chimiques
Antigens, Viral, Tumor
0
Viral Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1008562Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Cancer Res. 2017 Jun 15;77(12):3151-3157
pubmed: 28512245
Int J Cancer. 2009 Sep 15;125(6):1243-9
pubmed: 19499546
Curr Opin Virol. 2015 Apr;11:38-43
pubmed: 25681708
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16272-7
pubmed: 18812503
Crit Rev Biochem Mol Biol. 2017 Aug;52(4):395-413
pubmed: 28427283
J Pathol. 2009 May;218(1):48-56
pubmed: 19291712
Int J Cancer. 2016 Nov 1;139(9):2001-11
pubmed: 27343048
J Virol. 2010 Jul;84(14):7064-72
pubmed: 20444890
Viruses. 2017 Apr 10;9(4):
pubmed: 28394272
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Nat Biotechnol. 2012 Aug;30(8):771-6
pubmed: 22797562
J Biol Chem. 2018 Jul 6;293(27):10536-10546
pubmed: 29530982
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
J Mol Diagn. 2020 Apr;22(4):476-487
pubmed: 32068070
Genes Cells. 2011 Jan;16(1):23-33
pubmed: 21059156
Cancers (Basel). 2014 Oct 22;6(4):2155-86
pubmed: 25340830
Curr Opin Genet Dev. 2013 Jun;23(3):271-9
pubmed: 23790415
Infect Genet Evol. 2018 Jul;61:134-144
pubmed: 29518579
J Virol. 2013 Aug;87(16):9173-88
pubmed: 23760247
Science. 2008 Feb 22;319(5866):1096-100
pubmed: 18202256
Head Neck. 2016 May;38(5):647-52
pubmed: 26716756
PLoS Genet. 2009 Jan;5(1):e1000327
pubmed: 19180184
Cell. 2014 Jul 31;158(3):673-88
pubmed: 25083876
J Invest Dermatol. 2020 May;140(5):976-985
pubmed: 31759946
Bioinformatics. 2012 Feb 1;28(3):423-5
pubmed: 22155870
Curr Opin Virol. 2015 Oct;14:129-37
pubmed: 26447560
Virology. 2012 May 10;426(2):134-42
pubmed: 22342276
Nat Rev Dis Primers. 2017 Oct 26;3:17077
pubmed: 29072302
J Virol. 2014 Mar;88(6):3285-97
pubmed: 24390338
mBio. 2017 Jan 3;8(1):
pubmed: 28049147
PLoS Pathog. 2010 Aug 26;6(8):e1001076
pubmed: 20865165
Genome Res. 2009 Sep;19(9):1639-45
pubmed: 19541911
PLoS Pathog. 2017 Apr 6;13(4):e1006211
pubmed: 28384274
J Clin Invest. 2011 Sep;121(9):3623-34
pubmed: 21841310
Oncotarget. 2016 Jan 19;7(3):3403-15
pubmed: 26655088
Cell Host Microbe. 2016 Jun 8;19(6):775-87
pubmed: 27212661
Annu Rev Pathol. 2012;7:123-44
pubmed: 21942528
Nature. 2012 Sep 6;489(7414):57-74
pubmed: 22955616
PLoS Genet. 2018 Jan 24;14(1):e1007179
pubmed: 29364907
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):20104-20114
pubmed: 31527246
Bone Miner. 1991 Aug;14(2):113-20
pubmed: 1717086
PLoS Pathog. 2019 Oct 31;15(10):e1007838
pubmed: 31671162
Genome Res. 2014 Feb;24(2):185-99
pubmed: 24201445
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Invest Dermatol. 2013 Oct;133(10):2453-2460
pubmed: 23563200
J Invest Dermatol. 2015 May;135(5):1415-1424
pubmed: 25313532
Oncogene. 2018 Mar;37(11):1409-1416
pubmed: 29321666
J Mol Diagn. 2011 May;13(3):325-33
pubmed: 21497292
Nat Commun. 2019 Jan 23;10(1):392
pubmed: 30674876
Mutat Res. 2018 May;809:81-87
pubmed: 28754468
Nat Genet. 2015 Feb;47(2):158-63
pubmed: 25581428
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732):
pubmed: 28893943
Int J Cancer. 2017 Jul 1;141(1):160-171
pubmed: 28380668
PLoS One. 2015 Mar 20;10(3):e0119566
pubmed: 25793388
Int J Cancer. 2010 May 1;126(9):2133-42
pubmed: 19739110
J Virol. 2014 Mar;88(6):3144-60
pubmed: 24371076
Cell Host Microbe. 2010 Jun 25;7(6):509-15
pubmed: 20542254
Rev Med Virol. 1997 Jul;7(2):107-122
pubmed: 10398476
Clin Chem. 2019 Mar;65(3):462-472
pubmed: 30626636
J Virol. 2013 Jun;87(11):6118-26
pubmed: 23514892
Nature. 2007 May 3;447(7140):102-5
pubmed: 17410126
PLoS Pathog. 2015 Jul 28;11(7):e1004974
pubmed: 26218535
Eur J Cancer. 2015 Nov;51(16):2396-403
pubmed: 26257075
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13475-80
pubmed: 23898170
Mod Pathol. 2016 Mar;29(3):240-8
pubmed: 26743471
Cell. 1980 Nov;22(1 Pt 1):97-108
pubmed: 6253085
Lab Invest. 1987 Mar;56(3):302-12
pubmed: 3546933
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Cancer Immunol Immunother. 2018 Mar;67(3):341-351
pubmed: 29188306
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Genome Med. 2020 Mar 18;12(1):30
pubmed: 32188490
Lab Chip. 2019 Jul 9;19(14):2394-2403
pubmed: 31204419
JAMA Dermatol. 2017 Jun 1;153(6):505-512
pubmed: 28403382
J Invest Dermatol. 2014 Aug;134(8):2241-2250
pubmed: 24614157
Nanoscale. 2019 Jul 28;11(28):13620-13631
pubmed: 31290915
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Nat Struct Mol Biol. 2016 Apr;23(4):349-57
pubmed: 26926434
Nature. 2013 Oct 17;502(7471):389-92
pubmed: 24025772
Int J Cancer. 2019 Aug 15;145(4):1020-1032
pubmed: 30873613
Int J Cancer. 2010 Feb 1;126(3):796-8
pubmed: 19637243
PLoS Pathog. 2013;9(4):e1003283
pubmed: 23592994